LG Life Science LTD (068870)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:LG Life Science LTD (068870) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013613
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LG Life Science LTD (LGLS) is a global life science company that offers development, production and marketing of pharmaceutical products. The company provides pipeline of antibiotic, Factive and other drug candidates. Its products include vaccines, anti-infective, chemicals, veterinary medicine, fine chem, facial aesthetics, viscosupplements, products for hormones and fertility treatment. LGLS offers intermax gamma, intermax alpha, degenerative arthritis treatment, and others. The company’s target therapeutic areas include infectious disease, metabolic disease, urology, oncology, musculoskeletal, endocrinology, infertility, molecular diagnostics and others. It operates through its research center and plant, located in Korea. The company has operational presence in India, Poland, China and Jordan. LGLS is headquartered in Seoul, South Korea.

LG Life Science LTD (068870) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LG Life Science LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
LG Life Science LTD, Medical Devices Deals, 2011 to YTD 2017 9
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
LG Life Science LTD, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Lupin Enters into Distribution Agreement with LG Life Sciences for Insulin Analogue Glargine 11
Precision System Science Enters Into Distribution Agreement With LG Life Sciences 12
Chong Kun Dang Enters Into Distribution Agreement With LG Life Sciences For Uritos 13
LG Life Sciences Enters Into Co-Promotion Agreement With Sanofi-Aventis Korea For Zemiglo 14
Green Cross Enters Into Co-Promotion Agreement With LG Life Sciences For Shinbaro 15
Licensing Agreements 16
LG Life Sciences Enters into Licensing Agreement with Mochida Pharma 16
Ildong Enters Into Licensing Agreement With LG Life Sciences For Factive, Oral Quinolone Antibiotic 17
LG Life Sciences Enters Into License Agreement With Mochida For Biosimilar Antibody Drugs 18
LG Life Sciences Enters Into Licensing Agreement With Ildong Pharma For Besifovir 19
Novavax Enters Into Licensing Agreement With LG Life Sciences 20
LG Life Science LTD – Key Competitors 21
LG Life Science LTD – Key Employees 22
LG Life Science LTD – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
LG Life Science LTD, Pharmaceuticals & Healthcare, Key Facts, 2015 2
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LG Life Science LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LG Life Science LTD, Deals By Therapy Area, 2011 to YTD 2017 8
LG Life Science LTD, Medical Devices Deals, 2011 to YTD 2017 9
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lupin Enters into Distribution Agreement with LG Life Sciences for Insulin Analogue Glargine 11
Precision System Science Enters Into Distribution Agreement With LG Life Sciences 12
Chong Kun Dang Enters Into Distribution Agreement With LG Life Sciences For Uritos 13
LG Life Sciences Enters Into Co-Promotion Agreement With Sanofi-Aventis Korea For Zemiglo 14
Green Cross Enters Into Co-Promotion Agreement With LG Life Sciences For Shinbaro 15
LG Life Sciences Enters into Licensing Agreement with Mochida Pharma 16
Ildong Enters Into Licensing Agreement With LG Life Sciences For Factive, Oral Quinolone Antibiotic 17
LG Life Sciences Enters Into License Agreement With Mochida For Biosimilar Antibody Drugs 18
LG Life Sciences Enters Into Licensing Agreement With Ildong Pharma For Besifovir 19
Novavax Enters Into Licensing Agreement With LG Life Sciences 20
LG Life Science LTD, Key Competitors 21
LG Life Science LTD, Key Employees 22
LG Life Science LTD, Other Locations 23
LG Life Science LTD, Subsidiaries 23

★海外企業調査レポート[LG Life Science LTD (068870)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies. The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined. It offers RNAi technology platform GalXCTM, which is a advances …
  • Simplex Infrastructures Limited:戦略・SWOT・企業財務分析
    Simplex Infrastructures Limited - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Brake Bros Limited:企業の戦略的SWOT分析
    Brake Bros Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Michael Kors Holdings Ltd:企業の戦略・SWOT・財務情報
    Michael Kors Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Michael Kors Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Orsted AS:企業の発電所・SWOT分析2018
    Orsted AS - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Camlin Fine Sciences Ltd:企業の戦略・SWOT・財務情報
    Camlin Fine Sciences Ltd - Strategy, SWOT and Corporate Finance Report Summary Camlin Fine Sciences Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ricoh India Ltd:企業の戦略的SWOT分析
    Ricoh India Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Polaris Industries Inc.:企業の戦略・SWOT・財務分析
    Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dominion Energy Inc (D):石油・ガス:M&Aディール及び事業提携情報
    Summary Dominion Energy, Inc. (Dominion), formerly Dominion Resources, Inc., is a producer and transporter of energy. It carries out the generation, transmission and distribution of electricity; transmission, distribution, storage and processing of gas; and LNG import and storage activities. The com …
  • Genocea Biosciences Inc (GNCA):企業の財務・戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea Inc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tec …
  • Petropavlovsk Plc
    Petropavlovsk Plc - Strategy, SWOT and Corporate Finance Report Summary Petropavlovsk Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析
    Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Lophius Biosciences GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets T cell-based diagnostic systems and research tools in the areas of transplantation, infectious and autoimmune diseases. The company’s T-track immunoscan assay is a test in natural or induced immune modula …
  • KEC International Ltd:企業の戦略・SWOT・財務情報
    KEC International Ltd - Strategy, SWOT and Corporate Finance Report Summary KEC International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Toyo Tanso Co Ltd (5310):企業の財務・戦略的SWOT分析
    Toyo Tanso Co Ltd (5310) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hurricane Energy plc (HUR):企業の財務・戦略的SWOT分析
    Summary Hurricane Energy Plc (Hurricane) is an oil and gas exploration and development company that discovers and develops oil from fractured basement reservoirs. The company provides exploration properties such as lancaster basement prospect, whirlwind basement discovery, lincoln basement prospect, …
  • Wellington Management Company LLP:企業のM&A・事業提携・投資動向
    Wellington Management Company LLP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wellington Management Company LLP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • The Pep BoysManny, Moe & Jack:企業の戦略・SWOT・財務情報
    The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report Summary The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • United Technologies Corporation:企業の戦略・SWOT・財務情報
    United Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary United Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆